5-(2,6-Dichlorophenyl)-2-((2,4-difluorophenyl)thio)-6H-pyrimido(1,6-b)pyridazin-6-one
In Stock•Starting at $45 for 1 mg•Purity ≥ 98%
| CAS No. | 209410-46-8 |
|---|---|
| MDL No. | MFCD09834070 |
| MF | C19H9Cl2F2N3OS |
| MW | 436.30 |
| InChI Key | VEPKQEUBKLEPRA-UHFFFAOYSA-N |
Pricing & Availability
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| 1 mg | 98% | $45 | In Stock | |
| 5 mg | 98% | $54 | In Stock | |
| 25 mg | 98% | $132 | In Stock | |
| 50 mg | 98% | $222 | In Stock | |
Product Information
VX-745 is a pyrimidopyridazine, specifically a 6H-pyrimido[1,6-b]pyridazin-6-one substituted at positions 2 and 5 with (2,4-difluorophenyl)sulfanyl and 2,6-dichlorophenyl groups, respectively. It functions as an EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor, an anti-inflammatory drug, and an apoptosis inducer. It is also classified as a difluorobenzene, a dichlorobenzene, and an aryl sulfide.
| CAS No. | 209410-46-8 |
|---|---|
| Product Name | 5-(2,6-Dichlorophenyl)-2-((2,4-difluorophenyl)thio)-6H-pyrimido(1,6-b)pyridazin-6-one |
Biological Targets
MAPK14
Associated Conditions
Huntington disease·Dementia·Lewy body dementia·Cognitive impairment·Alzheimer disease
* The information provided here is compiled from public sources and is for reference only.